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The Comparison of Methods for Measuring
Oxidative Stress in Zebrafish Brains
Seyyed Hani Moussavi Nik,1 Kevin Croft,2 Trevor A. Mori,2 and Michael Lardelli1
Abstract
The zebrafish is a versatile model organism with the potential to contribute to our understanding of the
molecular pathological mechanisms underlying Alzheimer’s disease (AD). An early characteristic of AD brain
pathology is lipid peroxidation resulting from oxidative stress. However, changes in lipid peroxidation have not
yet been assessed in zebrafish brains, and an earlier attempt to observe changes in F2-isoprostane levels in the
brains of zebrafish exposed to hypoxia was unsuccessful. In this article, we examine the utility of various assays
of lipid peroxidation and more general assays of intracellular oxidative stress to detect the changes in oxidative
stress in the brains of adult zebrafish exposed to hypoxia or explanted into a sodium azide solution for chemical
mimicry of hypoxia. Levels of F2-isoprostanes and F4-neuroprostanes were low and variable in zebrafish brains
such that statistically significant changes due to hypoxia or chemical mimicry of hypoxia could not be observed.
However, measurement of lipid hydroperoxides did reveal significant changes in lipid peroxidation under these
conditions, while analyses of catalase gene expression and an assay based on 2¢,7¢-dicholorofluorescein oxi-
dation also revealed changes in oxidative stress levels.
Introduction
The human brain consumes *20% of the body’s en-ergy budget.1 Thus, supply of oxygen to the brain tissue is
critical for maintaining energy production and neural function.
Disruption of energymetabolism and especially mitochondrial
function may be fundamental to many neurodegenerative
diseases, including Alzheimer’s disease (AD).2 Neural hyp-
oxia can be a direct consequence of hypoperfusion, a common
vascular component among the AD risk factors.3 Hypoxia
causes the mitochondrial electron transport chain to emit in-
creased amounts of reactive oxygen species (ROS) at the Qo
site of complex III, which is consistent with increased oxida-
tive stress.4,5 Interestingly, a large body of evidence suggests
that oxidative stress plays an important role in the development
and progression of AD.6–8 Oxidative damage induced by ROS
has been extensively studied for neuronal lipids, proteins,
nucleic acids, and sugars in AD.9 The high lipid concentration
of the neuronal membrane, especially with respect to poly-
unsaturated fatty acids, and the high energy and oxygen con-
sumption rates of neurons make the brain susceptible to lipid
peroxidation.
F2-isoprostanes (F2-IsoPs) are a family of prostaglandin
(PG)-like bioactive compounds that are formed in vivo in-
dependently of cyclooxygenase. They are formed primarily
through free radical-mediated peroxidation of arachidonic
acid (AA10,11) and result in 32 isomers of F2-isoprostanes,
which are divided into four subfamilies (series 5, 8, 12,
and 15).10,12 Once formed, these compounds can be released
from phospholipids by phospholipases A2 (PLA2) or by
platelet activating factor acetylhydrolase (PAF-AH or lipo-
protein [Lp]-PLA2).13 F2-isoprostanes are named as such
because they contain F-type prostane rings and are isomeric
to PGF2a.
12
Docosahexaenoic acid (DHA) has been the subject of
considerable interest due to the fact that it is highly enriched
in the human brain, especially in the gray matter, where it
makes up *25%–35% of the total fatty acids in aminopho-
spholipids.14,15 Although DHA is present at high concentra-
tions in neurons, these cells are unable to elongate or
desaturate essential fatty acids to form DHA. Alternatively,
DHA is synthesized mainly by astrocytes, then secreted, and
taken up by neurons.16 Although the precise function of
DHA in the brain is not well understood, deficiency of
DHA is associated with abnormalities in brain function.17
Neuroprostanes (or F4-neuroprostanes [F4-NeuroPs]) are
isoprostane-like compounds that are formed by free radical-
induced peroxidation of DHA. F2-isoprostanes and neuro-
prostanes have been implicated in the pathogenesis of many
diseases and their potential roles in AD have also been
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investigated.18–20 F2-isoprostanes and neuroprostanes are the
most reliable biomarkers of in vivo lipid oxidation and oxi-
dative stress.21
The zebrafish is a versatile vertebrate model for studies of
developmental biology, genetics, pharmacology, and other
areas of neuroscience.22–24 Zebrafish have many inherent
advantages as a model organism, including low cost, easy
handling, and maintenance compared with other vertebrate
models, and around 70% protein sequence identity with hu-
mans.25 Oxidative stress and, in particular, lipid peroxidation
appears to be a critical part of the development of AD pa-
thology. For our work, to develop the zebrafish as a model
system in which to examine the molecular pathology of AD,
we must find sensitive and reliable methods to measure ox-
idative stress, including lipid peroxidation. In the previous
work, using zebrafish embryos and the brains from adult
fish, we attempted to examine relative oxidative stress after
exposure to hypoxia by examining F4-isoprostanes and lev-
els of catalase mRNA.26 No significant difference in F4-
isoprostane levels could be observed, whereas very significant
increases in catalase mRNA were seen under hypoxia.
Chemical mimicry of hypoxia using exposure of embryos or
explanted adult brains to a sodium azide (NaN3) solution
produces the same effects.27 In this article, we have examined
oxidative stress, including lipid peroxidation, using specific
methods such as measurement of F2-isoprostanes and F4-
neuroprostanes, and lipid hydroperoxides (LOOHs). We also
examined more general assays for ROS such as quanti-
tative PCR (qPCR) for catalase gene expression and di-
chlorofluorescein (DCF) measurement of intracellular ROS.
We show that concentrations of F2-isoprostanes and F4-
neuroprostanes are very low and variable, but lipid perox-
idation can be revealed in zebrafish brains bymeasurement of
LOOH. ROS is detectable by qPCR for catalase transcripts
and by DCF measurement of intracellular ROS.
Materials and Methods
Ethics
This work was conducted under the auspices of the Animal
Ethics Committee of the University of Adelaide and in ac-
cordance with the EC Directive 86/609/EEC for animal ex-
periments and the Uniform Requirements for Manuscripts
Submitted to Biomedical Journals.
Zebrafish husbandry and experimental procedures
Danio rerio were bred and maintained at 28C on a 14-h
light/10-h dark cycle.28 Wild-type zebrafish (AB strain) at
*1 year of age were used for all experiments. Both male and
female fish were used (i.e., except for qPCR analysis of
catalyse mRNA levels there was no differentiation on the
basis of gender). For chemical mimicry of hypoxia, adult
explant brain tissues were exposed to 100lM NaN3 (Sigma-
Aldrich Chemie GmbH, Steinheim, Germany) in the DMEM.
In studies of hypoxia, it is common to use chemical agents
that can mimic (partially) hypoxic conditions (also known as
chemical hypoxia). Agents commonly used are cobalt chlo-
ride (CoCl2), nickel chloride (NiCl2), and NaN3. Azides,
including NaN3, have an action on the respiratory chain very
similar to that of cyanide.27 In the experiments conducted
under low oxygen conditions, oxygen was depleted by bub-
bling nitrogen gas through the fish tank water. Oxygen con-
centrations were measured using a dissolved oxygen meter
(DO 6+; Eutech Instruments, Singapore). The dissolved
oxygen level in the hypoxia group was measured to be
1.15 – 0.6mg/L, whereas the normal ambient oxygen level
was 6.6 – 0.45mg/L. All experiments were performed with
three or six replicates (i.e., n= 3 or n = 6) as indicated. Briefly,
after each hypoxia trial, the animals were killed by plunging
into ice water and then brains removed.29 For F2-isoprostane
and F4-neuroprostane measurements, brains were removed
and frozen immediately in solid CO2 before eventual analysis
using three adult zebrafish brains per sample. Other assays
were conducted using freshly explanted brains with six brains
per sample.
Chemicals, reagents, and chromatography
15-F2t-IsoP (8-iso-PGF2a)and15-F2t-IsoP-d4 (8-iso-PGF2a-d4)
were purchased from Cayman Chemicals (Ann Arbor, MI)
and used without further purification. F4-neuroprostane
standard was kindly provided by Dr. Thierry Durand (Institut
des Biomole´cules Max Mousseron, Universite´ Montpellier I,
Montpellier France). Pentafluorobenzylbromide (PFBBr)
and N,N-diisopropylethylamine (DIPEA) were purchased
from Sigma Chemicals (St Louis, MO). The silylating agent
N,O-bis-(trimethylsilyl)trifluoroacetamide (BSTFA) with
1% trimethylchlorosilane (BSTFA-TMCS, 99:1) was pur-
chased from Pierce Chemicals (Rockford, IL). Certify II
cartridges were from Varian (Lake Forrest, CA). All solvents
were of HPLC grade. The 4(RS)-F4t-NeuroP (F4-IsoP) was
synthesized as previously described.30,31
Measurement of F4-NeuroPs and F2-IsoPs
F4-NeuroPs and F2-IsoPs were measured using a modifi-
cation of our previously reported method.32,33 Briefly, sam-
ples were spiked with 5 ng internal standard 15-F2t-IsoP-d4
(8-iso-PGF2a-d4), then hydrolyzed with 1M potassium hy-
droxide in methanol, acidified, and applied to prewashed
Certify II cartridges (Varian). After washing with methanol/
water (1:1) and hexane/ethyl acetate (75:25), the metabolites
were eluted with ethyl acetate/methanol (90:10) and dried
under vacuum. Samples were derivatized using PFBBr and
DIPEA (Sigma Chemicals), dried under nitrogen, and then
treated with the silylating agent BSTFA with 1% TMCS
(Pierce Chemicals). IsoFs, F2-IsoPs, and F4-NeuroPs were
quantified by gas chromatography–mass spectrometry using
electron capture negative ionization and selected ion moni-
toring. Ions monitored were m/z 569, 573, and 593, for F2-
IsoP, 15 F2t-IsoP-d4, and F4-NeuroPs, respectively.
Measurement of LOOHs
Lipid peroxidation in zebrafish adult brain was estimated
using an LOOH assay kit (Cayman Chemical Company, Ann
Arbor, MI). Zebrafish brain tissues from normoxic and actual
hypoxic and chemical mimicry of hypoxia were homoge-
nized in a buffer containing no transition metal ions [ice-cold
Tris-HCl buffer (containing 0.25M sucrose, pH 7.4), differ-
ential centrifugation (700 and 4500 g, 10min, 4C)]. Five
hundred microliters of homogenized brain was placed in
separate test tubes. An equal amount of Extract R saturated
methanol was added and mixed by vortexing. One milliliter
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of cold deoxygenated chloroform was added to all the control
and sample tubes and centrifuged at 1500 g for 5min at 0C
(Beckman XL-100K, Ramsey, MN). After centrifugation,
the chloroform layer (500lL) was mixed with 450 lL of
chloroform:methanol (2:1) and 50 lL of chromogen (thio-
cyanate ion). The reaction mixtures of all the control and
sample tubes were incubated at room temperature for 5min.
The absorbance of each control and sample was recorded at
500 nm using a research spectrophotometer.
Quantitative real-time PCR
The relative standard curve method for quantification was
used to determine the expression of experimental samples
compared with a basis sample. For experimental samples,
target quantity was determined from the standard curve and
then compared with the basis sample to determine fold
changes in expression. Gene-specific primers were designed
for amplification of target cDNA and the cDNA from the
ubiquitously expressed control gene eef-1a1a. The reaction
mixture consisted of 50 ng/lL of cDNA. Eighteen micro-
molars of forward and reverse primers and Power SYBR
green master mix PCR solution (Applied Biosystems, Foster
City, CA).
To generate the standard curve, cDNA was serially diluted
(100, 50, 25, 12.5 ng). Each sample and standard curve re-
actions were performed in triplicate for the control gene and
experimental genes. Amplification conditions were 2min at
50C followed by 10min at 95C, and then 40–45 cycles of
15 s at 95C and 1min at 60C. Amplification was performed
on an ABI 7000 Sequence Detection System (Applied Bio-
systems) using 96-well plates. Cycle thresholds obtained
from each triplicate were averaged and normalized against
the expression of eef-1a1a, which has previously been
demonstrated to be suitable for normalization for zebrafish
qPCR.34 Each experimental sample was then compared with
the basis sample to determine fold changes of expression. The
primers used for quantitative real-time PCR analysis of cat-
alase mRNA levels were cat F: (5¢-TAAAGGAGCAGGA
GCGTTTGGCTA-3¢) and cat R: (5¢-TTCACTGCGAAACC
ACGAGGATCT-3¢).
Evaluation of intracellular ROS production
ROS production was measured following the method
based on 2¢,7¢-dichlorofluorescein oxidation.35 Zebrafish
brain tissues from normoxic and hypoxic conditions were
homogenized in an ice-cold Tris-HCl buffer (containing
0.25M sucrose, pH 7.4). Differential centrifugation (700 and
4500 g, 10min, 4C) was employed to isolate cytosol and
mitochondria from the brain tissue. Homogenates from total
zebrafish brain (60 lL) were incubated for 30min at 37C in
the dark with 240 lL of 100lM 2¢,7¢-dichlorofluorescein
diacetate (H2DCF-DA) solution in a 96-well plate. H2DCF-
DA is cleaved by cellular esterases and the H2DCF formed is
eventually oxidized by ROS present in samples. The last
reaction produces the fluorescent compound DCF, which was
measured at 488 nm excitation and 525 nm emission, and the
results were presented as DCF fluorescence intensity. A
calibration curve was produced using purified DCF as a
standard. To exclude the possibility of false signals arising
from reactions with NaN3, a volume of 100 lM NaN3
equivalent to the volume of zebrafish brain in the assay
(100 lL) was incubated with DCF and measured at 488 nm
excitation and 525 nm emission, with the results presented as
DCF fluorescence intensity.
Statistical analysis of data
Means and standard deviations were calculated for all
variables. A Student’s t-test was used to evaluate significant
differences between controls and samples from different
treatments. p-Values, degrees of freedom (df), and t-values
are shown within the figures and figure legends. A criterion
alpha level of p < 0.05 was used for all statistical compari-
sons. Values given in figures represent means – SEMs of
brains from three animals per biological replicate (three
replicates per assay) for qPCR, DCF, and LOOH assays. For
IsoPs and NeuroPs, values represent means – SEMs of brains
from one animal per biological replicate (six replicates per
assay). All data were analyzed using GraphPad Prism version
6.0 (GraphPad Prism, La Jolla, CA).
Results
Catalase expression validates oxidative stress conditions
To support that oxidative stress had been produced under
our experimental conditions, we examined the relative ex-
pression of the gene encoding Catalase cat that has previ-
ously been used as a marker of oxidative stress in
zebrafish.36,37 We previously reported that cat mRNA levels
are increased in the brains of zebrafish exposed to actual
hypoxia.26 For the work described in this article, we analyzed
relative cat mRNA levels by qPCR in explanted zebrafish
brains under chemical mimicry of hypoxia and actual hyp-
oxia from both female and male zebrafish. We found that,
under chemical mimicry of hypoxia and actual hypoxia, cat
mRNA levels are increased more than twofold in the brains of
both female and male zebrafish. This supports that incubation
of explanted adult brains in 100 lM NaN3 for 6 h is a valid
method for mimicry of hypoxia in this tissue (Fig. 1). No
significant differences were seen due to brain gender. Sub-
sequent analyses did not differentiate between the gender of
the individuals.
Measurement of intracellular ROS production
In their analysis of the effects of respiratory burst re-
sponse in zebrafish, Hermann et al. measured intracellular
ROS in embryos by evaluating changes in the fluorescence
intensity of the dye DCF.38 Embryos at various develop-
mental stages were found to oxidize the probe to different
extents. Significant amounts of ROS were produced only in
embryos of 3 dpf and older.38 Seibt et al. also described
changes in intracellular ROS by evaluating changes in the
fluorescence intensity of the dye DCF after treatment with
antipsychotic drugs on zebrafish brains.39 We tested whe-
ther DCF might be useful for assessing ROS induced by
actual hypoxia and/or chemical mimicry of hypoxia in
zebrafish brains. When zebrafish were exposed to hypoxia
for 3 h (Fig. 2A) or explanted brains were incubated with
100 lM of NaN3 at 28C for 6 h (Fig. 2B), both revealed
significantly increased intracellular ROS by DCF fluores-
cence. A control in which a volume of 100 lM of NaN3
equivalent to the zebrafish brain volumes used in the assay
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incubated with DCF showed no evidence of any false signal
due to the reaction of NaN3 and DCF (Fig. 2B).
F2-isoprostane and F4-neuroprostane levels in
zebrafish brain tissue under hypoxic stress
To determine whether F2-isoprostane and/or F4-neuro-
prostane levels might reveal changes in lipid peroxidation
under oxidative stress conditions, we first examined their
levels in brains from adult zebrafish exposed to hypoxia for
3 h or in explanted zebrafish brains subjected to chemical
mimicry of hypoxia by incubation in 100lM NaN3 for 6 h.
No significant differences from normoxia were seen for F2-
IsoPs (Supplementary Fig. S1; Supplementary Data are
available online at www.liebertpub.com/zeb) or F4-NeuroPs
(Supplementary Fig. S2) levels under either actual hypoxia or
chemical mimicry of hypoxia. The lack of observable chan-
ges may be due to the variability seen for the levels of these
molecules between individuals.We found that F2-isoprostane
and F4-neuroprostane levels were generally low in zebrafish
brain (*4 and*15 pg/mg, respectively) relative to the brains
of mammals. The levels of AA and DHA in fish brain tissue
are very low (1% and 5% of total fatty acids, respectively)
compared with the levels in the human brain (11% and 25%
of total fatty acids, respectively), which may contribute to
the low levels of F2-isoprostanes and F4-neuroprostanes
observed.40,41
Measurement of lipid peroxidation in zebrafish brain
tissue under hypoxic stress using a LOOH assay
LOOHs are derived from unsaturated lipids and choles-
terol. LOOHs are prominent intermediates of peroxidative
reactions induced by ROS, including hydroxyl radicals and
singlet oxygen.42 LOOH has previously been used to mea-
sure changes in lipid peroxidation in metabolic studies of
caudal fin muscle of zebrafish by Rosa et al.43 We measured
LOOH levels in explanted zebrafish brains subjected to
chemical mimicry of hypoxia by incubation in 100 lM
NaN3 for 6 h (Fig. 3A) in the brain tissue of zebrafish ex-
posed to actual hypoxia for 3 h (Fig. 3B). LOOH levels were
significantly increased approximately twofold in both cases
indicating that this assay can be used to detect changes in
lipid peroxidation in zebrafish brain for studies of the
mechanisms underlying AD pathology.
Discussion
A growing number of studies have exploited zebrafish to
examine the role of hypoxia in brain dysfunction. For ex-
ample, Braga et al. studied the effect of hypoxia on fish be-
havior.29 They confirmed that decreased oxygen levels
reduced the mitochondrial metabolic activity using a Tri-
phenyl tetrazolium chloride-based assay. Hypoxia also cau-
ses increased production of ROS by mitochondria and we
have previously monitored this indirectly by measuring rel-
ative catalase mRNA levels using qPCR.26 However, for
modeling of the oxidative stress associated with AD, more
direct measures of ROS are desirable. In this study, we have
sought to continue our development of the zebrafish as a
model for analysis of the molecular pathology of AD by
examining other, more direct, assays of ROS in the brains of
zebrafish exposed to hypoxia and chemical mimicry of
hypoxia.
The role of hypoxia-induced oxidative damage in the
pathogenesis of neurodegenerative disorders has been firmly
established.44,45 Increases in oxidative stress occur when
there is an imbalance between ROS generation and antioxi-
dant defenses. The increase in ROS production is due to
mitochondrial dysfunction caused by hypoxia.4 There are
multiple pathological consequences of increased ROS pro-
duction.46 In particular, markers of lipid peroxidation have
been found to be elevated in brain tissues and body fluids in
several neurodegenerative diseases, including AD, Parkin-
son’s disease, amyotrophic lateral sclerosis, Huntington’s
disease, and Down syndrome.47–49
The brain is highly vulnerable to oxidative stress because
of its high rate of oxygen consumption, its low level of
antioxidant defenses, and also its high lipid concentration
providing substrates for lipid peroxidation.46 In AD brain,
increased lipid peroxidation has been identified by measuring
levels of free and protein-bound 4-hydroxy-2-nonenal
(HNE), F2-isoprostanes, and F4-neuroprostanes.
50,51 Pratico
et al. showed increased levels of the isoprostane 8, 12-iso-
iPF2a-VI, in cerebrospinal fluid in AD and mild cognitive
FIG. 1. Quantitative PCR analysis of
zebrafish cat mRNA levels in explanted
zebrafish brains [male and female (n = 3)]
under normoxia relative to under chemical
mimicry of hypoxia. Fold changes in gene
expression are shown relative to normoxia
(****p < 0.0001).
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impairment (MCI) and suggested that this lipid peroxidation
product conceivably could be used as a marker to identify
MCI patients who are at increased risk of progression to
symptomatic AD.52,53
To verify that hypoxia causes oxidative stress and lipid
peroxidation in zebrafish brain tissue, F2-isoprostane and/or
F4-neuroprostane levels were measured. We also performed
qPCR analysis of catalase expression, LOOH assay, and DCF
to assess ROS. Our results revealed that exposure to acute
levels of actual hypoxia or chemical mimicry of hypoxia has
no consistentlymeasurable effect on highly specificmarkers of
lipid peroxidation, F2-isoprostane, and/or F4-neuroprostane
levels in zebrafish brain tissue. The lack of observable sig-
nificant changes may be due to the variability seen for the
levels of these molecules between individuals. We found that
F2-isoprostane and F4-neuroprostane levelswere generally low
in zebrafish brain (4 and 15pg/mg, respectively) relative to the
brains of mammals. As previously suggested in human stud-
ies54 and fish studies,55 the timing of sampling after a treatment
is important. Some fish may have a faster response to ROS to
release oxidized lipid products (isoprostanes, neuroprostanes),
some may take time, and some are even suppressed (7b-
hydroxycholesterol).54 However, exposure to actual hypoxia
or chemical mimicry of hypoxia significantly increased lipid
FIG. 2. (A) Measurement of intracellular reactive oxygen
species (ROS) production in the brains of zebrafish after
exposure to hypoxia. ROS are significantly increased. Error
bars show standard deviation (***p < 0.0012, t = 8.170,
df = 4). (B) Measurement of intracellular ROS in explanted
zebrafish brains under chemical mimicry of hypoxia.
Treatment with 100 lM sodium azide (NaN3) significantly
increased ROS after 6 h of exposure. No fluorescence signal
was observed for a negative control experiment in which the
assay was performed using a volume of 100lM NaN3
equivalent to the volume of zebrafish brain normally used in
the assay (NaN3 +H2DCF) (***p< 0.0011, t= 8.383, df = 4,
**p < 0.0025, t = 6.747, df= 4).
FIG. 3. (A) Levels of lipid hydroperoxide (LOOH) in
explanted brains of zebrafish exposed to NaN3 for chemical
mimicry of hypoxia. Error bars show standard deviation
(***p < 0.0002, t = 13.17, df= 4). (B) Levels of LOOH in
explanted brains of zebrafish Danio rerio after exposure to
actual hypoxia (**p < 0.0014, t = 7.849, df = 4).
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peroxidation as measured by the LOOH assay. LOOHs are
primary products of lipid peroxidation mainly generated from
phospholipids, cholesterol esters, and unsaturated fatty acids,
which are degraded to reactive aldehydes, such as HNE mal-
ondialdehyde and alkenals as secondary peroxidation prod-
ucts.42 Once formed, LOOHs undergo reductive degradation,
enhancing cytotoxic potential. In addition, LOOHs trigger
signal transduction pathways that lead to apoptosis.42 As far as
the behavior of hydroperoxide is concerned, our data are in
agreement with those of Hayashi et al. showing that formation
of hydroperoxides from phospholipids can be increased by the
presence of an amyloidb1–42-Cu
2+ complex.56
We also observed that intracellular ROS levels were sig-
nificantly increased in zebrafish brains exposed to actual
hypoxia or NaN3. These data are consistent with the idea that
insufficient oxygen supply may cause oxidative stress and
alterations in antioxidant enzymes observed early in the de-
velopment of AD.7 Indeed, Markesbery et al. and Pratico
et al.51,53 showed that levels of lipid peroxidation increased
significantly in brains of patients with AD when compared
with controls.
In summary, we have presented evidence from a number of
different assays that acute exposure to hypoxia or chemical
mimicry of hypoxia increases oxidative stress in zebrafish
brain tissue. Although F2-isoprostane and F4-neuroprostane
levels did not show significantly measurable alteration, lipid
peroxidation appeared to increase as demonstrated by the
lipid hydroperoxidase assay. Our findings show that exposure
of zebrafish to actual hypoxia or chemical mimicry of hyp-
oxia can produce biochemical changes similar to those ob-
served in AD. This supports the use of zebrafish as a useful
animal model for future investigation of the causes of, and
potential treatments for, AD.
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